Prosensa Holding N.V. (RNA) Misses Q4 EPS by 13c

Prosensa Holding N.V. (NASDAQ: RNA) reported Q4 EPS of ($0.79), $0.13 worse than the analyst estimate of ($0.66). Revenue for the quarter came in at $2.19 million versus the consensus estimate of $12.21 million.

For earnings history and earnings-related data on Prosensa Holding N.V. (RNA) click here.

You May Also Be Interested In

• Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• Is the global equity rally broadening? UBS weighs in
• S&P 500 may pull back before midterms, but Citi says buy the dip